Cyclooxygenase (COX)-1 activity precedes the COX-2 induction in Aβ-induced neuroinflammation

Journal of Molecular Neuroscience

Volumn 45, Issue 1, 2011, Pages 10-21

  Dargahi, Leila ^a   Nasiraei Moghadam, Shiva ^a   Abdi, Azadeh ^a   Khalaj, Leila ^a   Moradi, Fatemeh ^a   Ahmadiani, Abolhassan ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Amyloid peptide; Cyclooxygenase 1; Cyclooxygenase 2; Neuroinflammation; Prostaglandin E2

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; AMYLOID BETA PROTEIN; CASPASE 3; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NERVE INJURY; NICK END LABELING; NONHUMAN; PREFRONTAL CORTEX; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; RAT;

AMYLOID BETA-PEPTIDES; ANIMALS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; ENCEPHALITIS; ENZYME INDUCTION; HIPPOCAMPUS; ISOENZYMES; MALE; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 79960932928     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-010-9401-6     Document Type: Article

References (75)

1. S Aid R Langenbach F Bosetti 2008 Neuroinflammatory response to lipopolysaccharide is exacerbated in mice genetically deficient in cyclooxygenase-2 J Neuroinflammation 5 7 10.1186/1742-2094-5-17 (Pubitemid 351803159)
2. PS Aisen KA Schafer M Grundman, et al. 2003 Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial J Am Med Assoc 289 2819 2826 10.1001/jama.289.21.2819 1:CAS:528: DC%2BD3sXktlKmsb0%3D (Pubitemid 37430117)
3. RS Akundi E Candelario-Jalil S Hess, et al. 2005 Signal transduction pathways regulating cyclooxygenase-2 in lipopolysaccharide-activated primary rat microglia Glia 51 199 208 15800925 10.1002/glia.20198 (Pubitemid 41297426)
4. SM Allan NJ Rothwell 2003 Inflammation in central nervous system injury Philos Trans R Soc B Biol Sci 358 1669 1677 10.1098/rstb.2003.1358 1:CAS:528:DC%2BD3sXpvFShtr0%3D (Pubitemid 37298635)
5. KI Andreasson A Savonenko S Vidensky, et al. 2001 Age-dependent cognitive deficits and neuronal apoptosis in cyclooxygenase-2 transgenic mice J Neurosci 21 8198 8209 11588192 1:CAS:528:DC%2BD3MXoslGitrw%3D (Pubitemid 32952775)
6. C Bate R Veerhuis P Eikelenboom A Williams 2003 Neurons treated with cyclo-oxygenase-1 inhibitors are resistant to amyloid-beta1-42 NeuroReport 14 2099 2103 14600505 10.1097/00001756-200311140-00018 1:CAS:528: DC%2BD3sXoslWltb8%3D
7. V Blais NP Turrin S Rivest 2005 Cyclooxygenase 2 (COX-2) inhibition increases the inflammatory response in the brain during systemic immune stimuli J Neurochem 95 1563 1574 16277613 10.1111/j.1471-4159.2005.03480.x 1:CAS:528:DC%2BD28XhsVKisg%3D%3D (Pubitemid 41804054)
8. E Candelario-Jalil A Gonzalez-Falcon M Garcia-Cabrera, et al. 2003 Assessment of the relative contribution of COX-1 and COX-2 isoforms to ischemia induced oxidative damage and neurodegeneration following transient global cerebral ischemia J Neurochem 86 545 555 12859668 10.1046/j.1471-4159.2003. 01812.x 1:CAS:528:DC%2BD3sXlvF2ntb8%3D (Pubitemid 36897435)
9. NV Chandrasekharan DL Simmons 2004 The cyclooxygenases Genome Biol 5 241 15345041 10.1186/gb-2004-5-9-241 1:CAS:528:DC%2BD2cXot1WntLs%3D (Pubitemid 39335025)
10. SH Choi R Langenbach F Bosetti 2008 Genetic deletion or pharmacological inhibition of cyclooxygenase-1 attenuate lipopolysaccharide-induced inflammatory response and brain injury J Fed Am Soc Exp Biol 22 1491 1501 1:CAS:528:DC%2BD1cXltlWks70%3D (Pubitemid 351656789)
11. SH Choi S Aid F Bosetti 2009 The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research Trends Pharmacol Sci 30 174 181 19269697 10.1016/j.tips.2009.01.002 1:CAS:528:DC%2BD1MXjslOksbg%3D
12. DW Chung KY Yoo IK Hwang, et al. 2010 Systemic administration of lipopolysaccharide induces cyclooxygenase-2 immunoreactivity in endothelium and increases microglia in the mouse hippocampus Cell Mol Neurobiol 30 4 531 541 19908141 10.1007/s10571-009-9477-0 1:CAS:528:DC%2BC3cXmsVSlt7k%3D
13. M Combrinck J Williams MA De Berardinis, et al. 2006 Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease J Neurol Neurosurg Psychiatry 77 85 88 15944180 10.1136/jnnp.2005.063131 1:STN:280:DC%2BD2MnntlOksg%3D%3D (Pubitemid 43022699)
14. V Echeverria S Burgess J Gamble-George, et al. 2009 Sorafenib inhibits nuclear factor kappa B, decreases inducible nitric oxide synthase and cyclooxygenase-2 expression, and restores working memory in APPswe mice Neuroscience 162 1220 1231 19447162 10.1016/j.neuroscience.2009.05.019 1:CAS:528:DC%2BD1MXps1aitbk%3D
15. LD Estrada C Soto 2007 Disrupting beta-amyloid aggregation for Alzheimer disease treatment Curr Top Med Chem 7 115 126 17266599 10.2174/ 156802607779318262 1:CAS:528:DC%2BD2sXht1Wjs7c%3D (Pubitemid 46062400)
16. JC Fehrenbacher TH Burkey GD Nicol MR Vasko 2005 Tumor necrosis factor alpha and interleukin-1beta stimulate the expression of cyclooxygenase II but do not alter prostaglandin E2 receptor mRNA levels in cultured dorsal root ganglia cells Pain 113 113 122 15621371 10.1016/j.pain.2004.09.031 1:CAS:528: DC%2BD2cXhtFCqtrnE (Pubitemid 40038452)
17. P Ferrera C Arias 2005 Differential effects of COX inhibitors against beta-amyloid-induced neurotoxicity in human neuroblastoma cells Neurochem Int 47 589 596 16169124 10.1016/j.neuint.2005.06.012 1:CAS:528:DC%2BD2MXhtFSis7jN (Pubitemid 41437904)
18. BL Fiebich S Schleicher O Spleiss M Czygan M Hull 2001 Mechanisms of prostaglandin E2-induced interleukin-6 release in astrocytes: possible involvement of EP4-like receptors, p38 mitogen activated protein kinase and protein kinase C J Neurochem 79 950 958 11739606 10.1046/j.1471-4159.2001.00652. x 1:CAS:528:DC%2BD3MXptFOhsLY%3D (Pubitemid 33117073)
19. T Harkany T Hortobagyi M Sasvari, et al. 1999 Neuroprotective approaches in experimental models of beta-amyloid neurotoxicity: relevance to Alzheimer's disease Prog Neuro Psychopharmacol Biol Psychiatry 23 963 1008 10.1016/S0278-5846(99)00058-5 1:CAS:528:DyaK1MXmsVaqtL0%3D (Pubitemid 29468909)
20. MT Heneka MK O'Banion 2007 Inflammatory processes in Alzheimer's disease J Neuroimmunol 184 69 91 17222916 10.1016/j.jneuroim.2006.11.017 1:CAS:528:DC%2BD2sXislejtLo%3D (Pubitemid 46365992)
21. L Ho JD Luterman PS Aisen GM Pasinetti TJ Montine JD Morrow 2000 Elevated CSF prostaglandin E2 levels in patients with probable AD Neurology 55 323 10908926 1:STN:280:DC%2BD3czpvVejtg%3D%3D
22. L Ho D Purohit V Haroutunian, et al. 2001 Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease Arch Neurol 58 487 492 11255454 10.1001/archneur.58.3.487 1:STN:280:DC%2BD3M7pvVChsQ%3D%3D (Pubitemid 32217467)
23. JJ Hoozemans AJ Rozemuller I Janssen CJ de Groot R Veerhuis P Eikelenboom 2001 Cyclooxygenase expression in microglia and neurons in Alzheimer's disease and control brain Acta Neuropathologica Berl 101 2 8 1:CAS:528: DC%2BD3MXhtValtbc%3D (Pubitemid 32124493)
24. JJ Hoozemans R Veerhuis I Janssen EJ van Elk AJ Rozemuller P Eikelenboom 2002 The role of cyclo-oxygenase 1 and 2 activity in prostaglandin E(2) secretion by cultured human adult microglia: implications for Alzheimer's disease Brain Res 951 218 226 12270500 10.1016/S0006-8993(02)03164-5 1:CAS:528:DC%2BD38Xnt1ajur4%3D (Pubitemid 35248018)
25. JJ Hoozemans MK Brückner AJ Rozemuller R Veerhuis P Eikelenboom T Arendt 2002 Cyclin D1 and cyclin E are co-localized with cyclo-oxygenase 2 (COX-2) in pyramidal neurons in Alzheimer disease temporal cortex J Neuropathol Exp Neurol 61 678 688 12152783 1:CAS:528:DC%2BD38XmsVansr8%3D (Pubitemid 34851771)
26. JJ Hoozemans JM Rozemuller ES van Haastert R Veerhuis P Eikelenboom 2008 Cyclooxygenase-1 and -2 in the different stages of Alzheimer's disease pathology Curr Pharm Des 14 1419 1427 18537664 10.2174/138161208784480171 1:CAS:528:DC%2BD1cXns1ynu7s%3D (Pubitemid 351982549)
27. J Hu MJ LaDu LJ Van Eldik 1998 Apolipoprotein E attenuates beta-amyloid-induced astrocyte activation J Neurochem 71 1626 1634 9751196 10.1046/j.1471-4159.1998.71041626.x 1:CAS:528:DyaK1cXmt1Kit7o%3D (Pubitemid 28443035)
28. JY Im D Kim SG Paik PL Han 2006 Cyclooxygenase-2-dependent neuronal death proceeds via superoxide anion generation Free Radic Biol Med 41 960 972 16934679 10.1016/j.freeradbiomed.2006.06.001 1:CAS:528:DC%2BD28XovVWqsbo%3D (Pubitemid 44247547)
29. - concentration in cultured rat hippocampal neurons Neurosci Lett 367 156 159 15331142 10.1016/j.neulet.2004.05.103 1:CAS:528:DC%2BD2cXntFWqsb8%3D (Pubitemid 39141216)
30. GH Jeohn LY Kong B Wilson P Hudson JS Hong 1998 Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures J Neuroimmunol 85 1 10 9626992 10.1016/S0165-5728(97)00204- X 1:CAS:528:DyaK1cXisFalurc%3D (Pubitemid 28255432)
31. WE Kaufmann PF Worley J Pegg M Bremer P Isakson 1996 COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex Proc Natl Acad Sci U S A 93 2317 2321 8637870 10.1073/pnas.93.6.2317 1:CAS:528:DyaK28XhvVSktr0%3D (Pubitemid 26104347)
32. T Kawano J Anrather P Zhou, et al. 2006 Prostaglandin E-2 EP1 receptors: downstream effectors of COX-2 neurotoxicity Nat Med 12 225 229 16432513 10.1038/nm1362 1:CAS:528:DC%2BD28XhtFajsro%3D (Pubitemid 43214750)
33. A Klegeris PL McGeer 2005 Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti-inflammatory agents in the treatment of neurodegenerative disease Curr Alzheimer Res 2 355 365 15974901 10.2174/1567205054367883 1:CAS:528:DC%2BD2MXmtFKqurc%3D (Pubitemid 40980194)
34. LA Kotilinek MA Westerman Q Wang, et al. 2008 Cyclooxygenase-2 inhibition improves amyloid-beta-mediated suppression of memory and synaptic plasticity Brain 131 651 664 18292081 10.1093/brain/awn008 (Pubitemid 351294724)
35. W Li S Wu RW Hickey ME Rose J Chen SH Graham 2008 Neuronal cyclooxygenase-2 activity and prostaglandins PGE2, PGD2, and PGF2 alpha exacerbate hypoxic neuronal injury in neuron-enriched primary culture Neurochem Res 33 490 499 17763946 10.1007/s11064-007-9462-2 1:CAS:528:DC%2BD1cXhs1ahtro%3D (Pubitemid 351230451)
36. X Liang L Wu Q Wang, et al. 2007 Function of COX-2 and prostaglandins in neurological disease J Mol Neurosci 33 94 99 17901552 10.1007/s12031-007-0058-8 1:CAS:528:DC%2BD2sXhtFemu7rI (Pubitemid 47574964)
37. C Maihofner S Probst-Cousin M Bergmann W Neuhuber B Neundorfer D Heuss 2003 Expression and localization of cyclooxygenase-1 and -2 in human sporadic amyotrophic lateral sclerosis Eur J Neurosci 18 1527 1534 14511332 10.1046/j.1460-9568.2003.02879.x (Pubitemid 37215106)
38. NL Malinin S Wright P Seubert D Schenk I Griswold-Prenner 2005 Amyloid-beta neurotoxicity is mediated by FISH adapter protein and ADAM12 metalloprotease activity Proc Natl Acad Sci U S A 102 3058 3063 15710903 10.1073/pnas.0408237102 1:CAS:528:DC%2BD2MXitVSktLk%3D (Pubitemid 40299915)
39. MP Mattson B Cheng D Davis K Bryant I Lieberburg RE Rydel 1992 Beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity J Neurosci 12 376 389 1346802 1:CAS:528:DyaK38XhvFajs74%3D
40. T Melnikova A Savonenko Q Wang, et al. 2006 Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern Neuroscience 141 1149 1162 16753269 10.1016/j.neuroscience.2006.05.001 1:CAS:528:DC%2BD28Xns12kur0%3D (Pubitemid 44128685)
41. L Minghetti 2004 Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases J Neuropathol Exp Neurol 63 901 910 15453089 1:CAS:528:DC%2BD2cXotFajt7k%3D (Pubitemid 39202493)
42. I Morita 2002 Distinct functions of COX-1 and COX-2 Prostaglandins Other Lipid Mediat 68-69 165 175 12432916 10.1016/S0090-6980(02)00029-1 (Pubitemid 35247394)
43. EE Netland JL Newton RE Majocha BA Tate 1998 Indomethacin reverses the microglial response to amyloid beta-protein Neurobiol Aging 19 201 204 9661994 10.1016/S0197-4580(98)00047-5 1:CAS:528:DyaK1cXktlCgsbg%3D (Pubitemid 28331296)
44. GD Nicol DK Klingberg MR Vasko 1992 Prostaglandin E2 increases calcium conductance and stimulates release of substance P in avian sensory neurons J Neurosci 12 1917 1927 1374463 1:CAS:528:DyaK38XktVClsbg%3D
45. M Nivsarkar A Banerjee H Padh 2008 Cyclooxygenase inhibitors: a novel direction for Alzheimer's management Pharmacol Rep 60 692 698 19066416 1:CAS:528:DC%2BD1MXisFCgtLg%3D
46. 1-42 on neuronal cells Acta Anatomica Sinica 39 804 809 1:CAS:528:DC%2BD1MXhtFWnsL%2FI
47. D Paris KP Townsend DF Obregon J Humphrey M Mullan 2002 Pro-inflammatory effect of freshly solubilized beta-amyloid peptides in the brain Prostaglandins Other Lipid Mediat 70 1 12 12428674 10.1016/S0090-6980(02)00111-9 1:CAS:528:DC%2BD38XptVOqsL0%3D
48. GM Pasinetti PS Aisen 1998 Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain Neuroscience 87 319 324 9740394 10.1016/S0306-4522(98)00218-8 1:CAS:528:DyaK1cXlsV2jtr4%3D (Pubitemid 28370892)
49. Paxinos G, Watson C (2007) The rat brain in stereotaxic coordinate, 6th edn. Academic, New York
50. O Pepicelli E Fedel M Berardi, et al. 2005 Cyclooxygenase-1 and -2 differently contribute to prostaglandin E2 synthesis and lipid peroxidation after in vivo activation of N-methyl-D-aspartate receptors in rat hippocampus J Neurochem 93 1561 1567 15935072 10.1111/j.1471-4159.2005.03150.x 1:CAS:528:DC%2BD2MXlsFemsLs%3D (Pubitemid 40853279)
51. RL Richardson E Kim RA Shephar T Gardiner J Cleary E O'Hare 2002 Behavioural and histopathological analyses of ibuprofen treatment on the effect of aggregated Abeta (1-42) injections in the rat Brain Res 954 1 10 12393227 10.1016/S0006-8993(02)03006-8 1:CAS:528:DC%2BD38XotVektrs%3D (Pubitemid 35230002)
52. J Rogers LC Kirby SR Hempelman, et al. 1993 Clinical trial of indomethacin in Alzheimer's disease Neurology 43 1609 1611 8351023 1:STN:280:DyaK3szlsVGrtw%3D%3D (Pubitemid 23230557)
53. S Sanz-Blasco RA Valero I Rodríguez-Crespo C Villalobos L Núñez 2008 Mitochondrial Ca2+ overload underlies Abeta oligomers neurotoxicity providing an unexpected mechanism of neuroprotection by NSAIDs PLoS ONE 3 e2718 18648507 10.1371/journal.pone.0002718
54. JM Schwab TD Nguyen E Postler R Meyermann HJ Schluesener 2000 Selective accumulation of cyclooxygenase-1-expressing microglial cells/macrophages in lesions of human focal cerebral ischemia Acta Neuropathologica Berl 99 609 614 10.1007/s004010051170 1:CAS:528:DC%2BD3cXjtVWrsbw%3D (Pubitemid 30307369)
55. JM Schwab R Beschorner R Meyermann F Gozalan HJ Schluesener 2002 Persistent accumulation ofcyclooxygenase-1-expressing microglial cells and macrophages and transient upregulation by endothelium in human brain injury J Neurosurg 96 892 899 12005397 10.3171/jns.2002.96.5.0892 1:CAS:528: DC%2BD38XjslCrtrw%3D (Pubitemid 34415404)
56. DJ Selkoe 2001 Alzheimer's disease: genes, proteins, and therapy Physiol Rev 81 741 766 11274343 1:CAS:528:DC%2BD3MXislCrsLc%3D (Pubitemid 32267077)
57. FS Shie RM Breyer TJ Montine 2005 Microglia lacking E prostanoid receptor subtype 2 have enhanced abeta phagocytosis yet lack abeta-activated neurotoxicity Am J Pathol 166 1163 1172 15793296 10.1016/S0002-9440(10)62336-X 1:CAS:528:DC%2BD2MXjsFaksLc%3D (Pubitemid 40524440)
58. FS Shie KS Montine RM Breyer TJ Montine 2005 Microglial EP2 is critical to neurotoxicity from activated cerebral innate immunity Glia 52 70 77 15920732 10.1002/glia.20220 (Pubitemid 41532139)
59. DL Simmons RM Botting T Hla 2004 Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition Pharmacol Rev 56 387 437 15317910 10.1124/pr.56.3.3 1:CAS:528:DC%2BD2cXotVKjtbY%3D (Pubitemid 39096597)
60. KI Strauss 2008 Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brain Brain Behav Immun 22 285 298 17996418 10.1016/j.bbi.2007.09.011 1:CAS:528:DC%2BD1cXhsFyls7o%3D (Pubitemid 351187774)
61. A Suzumura H Takeuchi G Zhang R Kuno T Mizuno 2006 Roles of glia-derived cytokines on neuronal degeneration and regeneration Ann N Y Acad Sci 1088 219 229 17192568 10.1196/annals.1366.012 1:CAS:528:DC%2BD2sXhtlShsLo%3D (Pubitemid 47092033)
62. T Takadera Y Shiraishi T Ohyashiki 2004 Prostaglandin E2 induced caspase-dependent apoptosis possibly through activation of EP2 receptors in cultured hippocampal neurons Neurochem Int 45 713 719 15234114 10.1016/j.neuint.2004.02.005 1:CAS:528:DC%2BD2cXlsVart7g%3D (Pubitemid 38844893)
63. P Teismann K Tieu DK Choi, et al. 2003 Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration Proc Natl Acad Sci U S A 100 5473 5478 12702778 10.1073/pnas.0837397100 1:CAS:528:DC%2BD3sXjs1yitbc%3D (Pubitemid 36542729)
64. K Ueda Y Fukui H Kageyama 1994 Amyloid beta protein-induced neuronal cell death: neurotoxic properties of aggregated amyloid beta protein Brain Res 639 240 244 7515762 10.1016/0006-8993(94)91736-1 1:CAS:528:DyaK2cXitFCgu7w%3D (Pubitemid 24078561)
65. M Van der Stelt C Mazzola G Esposito, et al. 2006 Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels Cell Mol Life Sci 63 1410 1424 16732431 10.1007/s00018-006-6037-3 (Pubitemid 43939021)
66. JR Vane YS Bakhle RM Botting 1998 Cyclooxygenases 1 and 2 Annu Rev Pharmacol Toxicol 38 97 120 9597150 10.1146/annurev.pharmtox.38.1.97 1:CAS:528:DyaK1cXivF2itro%3D (Pubitemid 28231490)
67. S Weggen M Rogers J Eriksen 2007 NSAIDs: small molecules for prevention of Alzheimer's disease or precursors for future drug development? Trends Pharmacol Sci 28 536 543 17900710 10.1016/j.tips.2007.09.004 1:CAS:528:DC%2BD2sXhtFeiurzI (Pubitemid 47488508)
68. Y Xia K Yamagata TL Krukoff 2006 Differential expression of the CD14/TLR4 complex and inflammatory signaling molecules following i.c.v. administration of LPS Brain Res 1095 85 95 16697357 10.1016/j.brainres.2006.03.112 1:CAS:528:DC%2BD28Xls1eisLg%3D (Pubitemid 43866012)
69. Z Xiang L Ho S Yemul 2002 Cyclooxygenase-2 promotes amyloid plaque deposition in a mouse model of Alzheimer's disease neuropathology Gene Expr 10 271 278 12450219 1:CAS:528:DC%2BD38XptlCgs7g%3D (Pubitemid 35315389)
70. J Xu S Wang Y Lin L Cao R Wang Z Chi 2009 Ghrelin protects against cell death of hippocampal neurons in pilocarpine-induced seizures in rats Neurosci Lett 453 58 61 19429016 10.1016/j.neulet.2009.01.067 1:CAS:528: DC%2BD1MXivVeiurc%3D
71. K Yamagata KI Andreasson WE Kaufmann CA Barnes PF Worley 1993 Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids Neuron 11 371 386 8352945 10.1016/0896-6273(93) 90192-T 1:CAS:528:DyaK2cXht1Ghu7k%3D (Pubitemid 23250354)
72. H Yang C Chen 2008 Cyclooxygenase-2 in synaptic signaling Curr Pharm Des 14 1443 1451 18537667 10.2174/138161208784480144 1:CAS:528:DC%2BD1cXns1ynu7c%3D (Pubitemid 351993045)
73. K Yasojima C Schwab EG McGeer PL McGeer 1999 Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs Brain Res 830 226 236 10366679 10.1016/S0006-8993(99)01389-X 1:CAS:528:DyaK1MXjtl2qsLk%3D (Pubitemid 29297950)
74. AV Yermakova J Rollins LM Callahan J Rogers MK O'Banion 1999 Cyclooxygenase-1 in human Alzheimer and control brain: quantitative analysis of expression by microglia and CA3 hippocampal neurons J Neuropathol Exp Neurol 58 1135 1146 10560656 10.1097/00005072-199911000-00003 1:CAS:528:DyaK1MXnvVartrY%3D (Pubitemid 29519837)
75. H Yue KI Strauss MR Borenstein MF Barbe LJ Rossi SA Jansen 2004 Determination of bioactive eicosanoids in brain tissue by a sensitive reversed-phase liquid chromatographic method with fluorescence detection J Chromatogr B Anal Technol Biomed Life Sci 803 267 277 10.1016/j.jchromb.2003.12. 027 1:CAS:528:DC%2BD2cXivVCkt70%3D (Pubitemid 38452448)